摘要
非酒精性脂肪性肝病(NAFLD)是目前最常见的肝脏疾病之一,其药物治疗目的主要是减缓或减少肝硬化、肝癌及肝衰竭等终末期肝病的发生,降低病死率。本文综述近年来胰岛素增敏剂、降脂药、抗氧化剂和肝细胞保护剂等各种NAFLD药物治疗方案的临床应用评价。
Non-alcoholic fatty liver disease （NAFLD） is one of the most common liver diseases. Drug treatment can slow and reduce the development of cirrhosis, liver cancer, liver failure and other end-stage liver disease. Particularly, it can reduce the mortality of liver relevant disease. This review summarizes drug treatment progress about NAFLD in recent years.
出处
《世界临床药物》
CAS
2013年第11期698-703,共6页
World Clinical Drug
基金
上海市医学重点专科建设计划项目资助(编号:ZK2012B20)
关键词
非酒精性脂肪性肝病
胰岛素增敏剂
降脂药
抗氧化剂
non-alcoholic fatty liver disease
insulin sensitizer
lipid-lowering drug
antioxidant agent
